Clinical trial
PET Using Hormone Receptor Ligands in Breast Cancer
NCT00647790 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PET Using Hormone Receptor Ligands in Breast Cancer
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- June 30, 2013
- Enrollment
- 79 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer